Mika K. Kaneko

Associate Professor

University Name

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Immunology Immunology professors in Japan

Contact this professor

LinkedIn

Google Scholar

Articles (17)

Anti-CD44 Variant 10 Monoclonal Antibody Exerts Antitumor Activity in Mouse Xenograft Models of Oral Squamous Cell Carcinomas

Year:

2024

Anti-HER2 Cancer-Specific mAb, H<sub>2</sub>Mab-250-hG<sub>1</sub>, Possesses Higher Complement-Dependent Cytotoxicity than Trastuzumab

Year:

2024

A Cancer-Specific Monoclonal Antibody against HER2 Exerts Antitumor Activities in Human Breast Cancer Xenograft Models

Year:

2024

Overcoming antibody-resistant SARS-CoV-2 variants with bispecific antibodies constructed using non-neutralizing antibodies

Year:

2024

Development of Highly Sensitive Anti-Mouse HER2 Monoclonal Antibodies for Flow Cytometry

Year:

2023

A Novel Anti-CD44 Variant 9 Monoclonal Antibody C<sub>44</sub>Mab-1 Was Developed for Immunohistochemical Analyses against Colorectal Cancers

Year:

2023

Development of a Novel Anti-CD44 Variant 5 Monoclonal Antibody C<sub>44</sub>Mab-3 for Multiple Applications against Pancreatic Carcinomas

Year:

2023

Development of a Novel Anti-CD44 Variant 7/8 Monoclonal Antibody, C<sub>44</sub>Mab-34, for Multiple Applications against Oral Carcinomas

Year:

2023

Identification of the Binding Epitope of an Anti-Mouse CCR6 Monoclonal Antibody (C<sub>6</sub>Mab-13) Using 1× Alanine Scanning

Year:

2023

A Humanized and Defucosylated Antibody against Podoplanin (humLpMab-23-f) Exerts Antitumor Activities in Human Lung Cancer and Glioblastoma Xenograft Models

Year:

2023

Defucosylated Monoclonal Antibody (H<sub>2</sub>Mab-139-mG<sub>2a</sub>-f) Exerted Antitumor Activities in Mouse Xenograft Models of Breast Cancers against Human Epidermal Growth Factor Receptor 2

Year:

2023

Proximity extracellular protein-protein interaction analysis of EGFR using AirID-conjugated fragment of antigen binding

Year:

2023

SARS-CoV-2 Spike Protein Mutation at Cysteine-488 Impairs Its Golgi Localization and Intracellular S1/S2 Processing

Year:

2022

A Defucosylated Anti-EpCAM Monoclonal Antibody (EpMab-37-mG2a-f) Exerts Antitumor Activity in Xenograft Model

Year:

2022

Antitumor Activity of an Anti-EGFR/HER2 Bispecific Antibody in a Mouse Xenograft Model of Canine Osteosarcoma

Year:

2022

Improved anti‐solid tumor response by humanized anti‐podoplanin chimeric antigen receptor transduced human cytotoxic T cells in an animal model

Year:

2022

Development of a Novel Anti-EpCAM Monoclonal Antibody for Various Applications

Year:

2022

Collaborators (7)

Tatsuya Sawasaki

Professor

Ehime University

JAPAN

Manabu Kawada

Laboratory Head

-

JAPAN

Hiroyuki Suzuki

Associate professor

Tohoku University

JAPAN

Taishi Onodera

Chief

National Institute of Infectious Diseases

JAPAN

Yukinari Kato

Professor

Tohoku University graduate school of medicine

JAPAN

Tomokazu Ohishi

-

JAPAN

Shin Kaneko

-

JAPAN

Social connections

How do I reach out?

Sign in for free to see their profile details and contact information.

Meet Kite AI